Dr. Qiang Cao is a distinguished scholar at Macau University of Science and Technology and Kunming University of Science and Technology. Dr. Cao's work is well recognized in the academic community, as evidenced by his publication of over 20 papers in prestigious SCI/SSCI journals, several of which he has served as the first or corresponding author. His research including the therapeutic efficacy of leonurine alkaloid in the treatment of cancer, mechanisms of antitumor action of BCL-2 inhibitor, and the impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer. This breadth of research showcases his versatility and deep knowledge in pharmacology and oncology. His work has not only advanced our understanding of pharmacology and traditional Chinese medicine but also underscored the importance of integrating diverse scientific traditions to tackle complex diseases like multiple myeloma.  

Yuquan Chen is a scholar in Epidemiology at Monash University, Melbourne, holding degrees from Hebei University and Tsinghua University. At Monash University, Chen's research has significantly impacted public health, epidemiology, and preventive medicine, as evidenced by an extensive array of publications, with over thirty-two papers in SCI-indexed journals. Beyond academia, Chen is a proactive member of the scientific community, contributing as an editor and reviewer for various esteemed journals. Additionally, Chen maintains an academic WeChat account, engaging a following of over 15,000, which highlights his commitment to public health education and preventive medicine. Through his rigorous research methodologies and steadfast dedication, Chen continues to contribute to a deeper understanding of health and wellness, providing insights that support the evolving dialogue between traditional practices and modern medical strategies.  

Qi Zhang is a renowned scholar in the field of public administration and public health, and has published more than 20 academic papers indexed by sci, including several esi highly cited papers.

Yanwei You is a scholar in the Division of Sports Science & Physical Education at Tsinghua University, renowned for his detailed examination of how exercise and sleep influence cognitive function and mental health, especially in young adults facing sleep challenges. His extensive research, evidenced by more than 30 papers in SCI-indexed journals and an H-index exceeding 10, has shed light on the vital connection between physical wellness and psychological well-being. Serving actively in the academic realm, You contributes as an editor and reviewer to numerous esteemed journals, such as Mediators of Inflammation and Frontiers in Public Health, highlighting his commitment to advancing the field. Through his work, You underlines the significance of holistic approaches in health, subtly aligning with integrated practices that meld traditional insights and modern scientific findings, thus enriching the discourse on comprehensive health strategies, including those relevant to chronic conditions like multiple myeloma.

Liangjing Xia is a distinguished scholar with substantial research achievements and academic accolades. She has received 18 notable awards, including the United Nations Environment Programme Youth Excellence Award. His innovative work has been recognized in several national and provincial innovation and entrepreneurship competitions. Since 2022, she has engaged in various significant research activities, including participating in research courses at Stanford University under the mentorship of a tenured professor and completing an online course on medical law at the University of Pennsylvania with a full scholarship. Liangjing Xia has published six academic papers, including four in SCI journals, with two as the first author. These works have collectively been cited 23 times. Additionally, she holds two authorized patents. Her research interests span the enzymatic synthesis of pharmaceuticals, the addiction mechanisms of natural compounds, and the pharmacological effects of active ingredients in traditional Chinese medicine. Her notable contributions to the treatment of non-tuberculous mycobacteria have also garnered public and media acknowledgment.

Dr. Shiyang Li currently serves as a research fellow for the Special Projects of Local Universities in Yunnan Province and leads several significant research projects funded by the Panzhihua Science and Technology Bureau. His extensive expertise lies in the field of heart failure and ischemic cardiomyopathy, particularly focusing on the analysis of genetic variants and their impact on disease prognosis. Dr. Li has spearheaded multiple provincial, municipal, and institutional projects, ranging from investigating the role of common variations in the SOD3 coding region on heart failure prognosis to real-world studies on the use of indobufen as an alternative treatment for post-PCI aspirin intolerance.His research not only delves into fundamental scientific inquiries but also addresses practical issues in clinical applications, thereby providing crucial theoretical support and practical guidance for medical management and disease treatment. Dr. Li has published eight high-quality papers in various SCI journals and one paper in a non-SCI journal, further attesting to his outstanding contributions to cardiovascular disease research and molecular target screening for oncology. His work plays a vital role in advancing the field of medical management research and offers novel insights and methods for precise treatment of related diseases.

Lexin Wang is a major scholar in the field of medical management and biomedical sciences, working at Ningxia Medical University, and has published dozens of sci-index academic papers with high academic impact.

Jiaan Lu is a key scholar in the field of medical management at Southwest Medical University and has been working on medical management for many years.

Li Yuxiao is an outstanding scholar with abundant research achievements and academic honors. She is an outstanding scholar in the field of statistics at Shandong University of Finance and Economics and the University of Exeter. Her innovative work has been recognized in multiple innovation and entrepreneurship competitions. Li Yuxiao has published 5 academic papers, including 1 SCI journal and 5 first author papers. In addition, she also holds an authorized patent. Her research interests mainly include the scientific integration of statistics and medicine, as well as the exploration and exploration of drug active ingredients, complex disease causes, and treatment plans.